Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 18, No 1 (2022) Cardiovascular Effects of Metformin Abstract  similar documents
B. T. Kurmanbekova, A. M. Noruizbaeva
"... , progression and mortality from cardiovascular diseases (CVD). The world communities are faced ..."
 
Vol 18, No 4 (2022) Uric Acid as a Risk Factor for Cardiovascular Diseases Abstract  similar documents
A. S. Safaryan, A. S. Lishuta, D. V. Nebieridze
"... Recently, hyperuricemia and its association with cardiovascular disease have been receiving more ..."
 
Vol 18, No 4 (2022) Parameters of the Infrastructure of the Residential Area and Their Relationship with Cardiovascular Risk Factors Abstract  similar documents
T. A. Mulerova, T. F. Gaziev, E. D. Bazdyrev, E. V. Indukaeva, D. P. Tsygankova, O. V. Nakhratova, A. S. Agienko, G. V. Artamonova
"... in Kemerovo Oblast and their connection to cardiovascular disease risk factors. Subjects and methods ..."
 
Vol 18, No 5 (2022) Assessment of Drug Related Problems and Pharmacist Interventions in Inpatients with Cardiovascular Disease Abstract  PDF (Eng)  similar documents
S. M. Biradar, B. Kohima, V. Nayak, S. Nandikol, V. Warad, S. M. Byakod, B. S. Hunasagi, S. R. Awasthi
"... of medications with cardiovascular disease patients by using PCNE Classification to assess and report drug ..."
 
Vol 17, No 6 (2021) Factors Determining the Three-Year Dynamics of Lipid Metabolism Indicators in Residents of a Large Industrial Region of Siberia Abstract  similar documents
D. P. Tsygankova, E. D. Bazdyrev, E. V. Indukaeva, A. S. Agienko, O. V. Nakhratova, G. V. Artamonova, O. L. Barbarash
 
Vol 18, No 2 (2022) Hostility, Anger, Psycho-emotional Factors and Cardiovascular Disease Abstract  similar documents
G. F. Andreeva, V. M. Gorbunov
"... , hostility, anger and cardiovascular diseases. The first chapter describes the main historical stages ..."
 
Vol 18, No 5 (2022) Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19 Abstract  similar documents
A. A. Smirnov, M. M. Loukianov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Maltseva, E. N. Belova, V. G. Klyashtorniy, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina
"... Aim. To study the clinical and anamnestic characteristics, pharmacotherapy of cardiovascular ..."
 
Vol 18, No 1 (2022) Cardioprotective Strategies for Doxorubicin-induced Cardiotoxicity: Present and Future Abstract  similar documents
A. M. Chaulin, D. V. Duplyakov
"... a high risk of developing or are at high risk of death from cardiovascular diseases. One of the main ..."
 
Vol 18, No 1 (2022) Prognostic Significance of the Integral Index of the Alcohol Situation in Assessing Regional Differences in Mortality from Cardiovascular Diseases in the Russian Federation Abstract  similar documents
B. E. Gornyi, A. M. Kalinina, O. M. Drapkina
"... . Material and methods. The dynamics of standardized mortality rate for cardiovascular diseases (CVD ..."
 
Vol 17, No 6 (2021) Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data) Abstract  similar documents
S. Yu. Martsevich, M. M. Lukyanov, M. M. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. V. Zagrebelnyy, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Smirnov, E. V. Kudryashov, I. V. Budaeva, E. S. Nikoshnova, O. E. Karpov, O. M. Drapkina
"... of prehospital pharmacotherapy of concomitant cardiovascular diseases (CVD). Material and methods. Patients were ..."
 
Vol 18, No 2 (2022) Antiarrhythmic and Hemodynamic Effects of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases Abstract  similar documents
A. N. Zakirova, N. E. Zakirova
"... the risk of developing cardiovascular diseases. Experimental studies have shown ω-3 PUFA are exhibiting ..."
 
Vol 18, No 1 (2022) The Impact of Combination Therapy with Rivaroxaban and Acetylsalicylic Acid in Patients with Coronary Heart Disease on the Achievement of the Target for Reducing Mortality from Cardiovascular Diseases of the Federal Project "Fight against Cardiovascular Diseases" Abstract  similar documents
M. V. Zhuravleva, A. V. Panov, A. R. Kuksenok
"... of the number of deaths due to cardiovascular disease (CVD), number of strokes and myocardial infarction ..."
 
1 - 12 of 12 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)